Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Shares Outstanding (Weighted Average): 2016-2025

Historic Shares Outstanding (Weighted Average) for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $126.9 million.

  • Organogenesis Holdings' Shares Outstanding (Weighted Average) fell 4.31% to $126.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $126.9 million, marking a year-over-year decrease of 4.31%. This contributed to the annual value of $132.6 million for FY2024, which is 0.41% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Shares Outstanding (Weighted Average) stood at $126.9 million, which was up 0.00% from $126.9 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Shares Outstanding (Weighted Average) peaked at $132.6 million during Q3 2024, and registered a low of $126.8 million during Q1 2025.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $130.5 million, with a median of $131.3 million in 2023.
  • As far as peak fluctuations go, Organogenesis Holdings' Shares Outstanding (Weighted Average) climbed by 21.98% in 2021, and later decreased by 4.31% in 2025.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' Shares Outstanding (Weighted Average) stood at $128.6 million in 2021, then increased by 1.97% to $131.2 million in 2022, then climbed by 0.66% to $132.0 million in 2023, then rose by 0.41% to $132.6 million in 2024, then dropped by 4.31% to $126.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $126.9 million for Q3 2025, versus $126.9 million for Q2 2025 and $126.8 million for Q1 2025.